Priftin Tablet, Film Coated
Product Images NDC 0088-2102

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Priftin (NDC 0088-2102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (3a64fb70 B85e 43d9 8bcd 7e893f568ae1 01)

Chemical structure of rifapentine, the active ingredient in Priftin 150 mg oral tablets. The diagram depicts the molecular arrangement of rifapentine with labeled atoms and bonds.*

FDA Label Image

Principal Display Panel (150 mg Tablet Blister Pack Carton)

Priftin rifapentine 150 mg film-coated tablets in a carton label showing branding, strength, and packaging details. The label indicates 24 tablets supplied as three 8-tablet blister strips. The manufacturer is sanofi-aventis U.S. LLC. Instructions for blister removal and storage conditions are also depicted on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.